Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma
- PMID: 25674294
- PMCID: PMC4313967
Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma
Abstract
An immunohistochemical study on the cells proliferative activity by Ki-67 protein and localization of the matrix metalloproteinase-9 and the inhibitor of matrix metalloproteinase-1 was carried out at the benign prostatic hyperplasia (BPH) and the adenocarcinoma (AC) of different Gleason's grades. A significant decrease of the MMP-9 and TIMP-1 level in the AC of different gradations was observed. A moderate positive correlation between the Gleason score and cell proliferation Ki-67 index (rs = 0.674) and a moderate negative correlation with the level of such a score and expression of MMP-9 (rs = -0.660) was detected. A weak negative correlation exists also between the level of proliferative activity of secretory cells and the expression of MMP-9 by tumor cells (rs = -0.369). The invasive properties of AC cells that promote a degradation of the basal membrane and connective tissue in prostate may be explained by the imbalance between the MMP-9 and TIMP-1, which expression is significantly reduced in AC, in comparison with BPH.
Keywords: Adenocarcinoma of the prostate; Ki-67; MMP-9; TIMP-1; collagen IV.
Figures


Similar articles
-
[Significance of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase and protein Ki-67 in prostate tumors].Urologiia. 2014 Sep-Oct;(5):82-6. Urologiia. 2014. PMID: 25807766 Russian.
-
Col IV and Fn distribution in prostatic adenocarcinoma and correlation of 67LR, MMP-9 and TIMP-1 expression with Gleason score.Anal Quant Cytol Histol. 2003 Oct;25(5):263-72. Anal Quant Cytol Histol. 2003. PMID: 14603723
-
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.Oncogene. 2003 Mar 6;22(9):1381-9. doi: 10.1038/sj.onc.1206154. Oncogene. 2003. PMID: 12618764
-
The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.Vojnosanit Pregl. 2015 Oct;72(10):906-13. doi: 10.2298/vsp131022069f. Vojnosanit Pregl. 2015. PMID: 26665557
-
Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.J Cell Physiol. 2002 May;191(2):208-16. doi: 10.1002/jcp.10092. J Cell Physiol. 2002. PMID: 12064464
Cited by
-
Characterization of Collagen Fibers (I, III, IV) and Elastin of Normal and Neoplastic Canine Prostatic Tissues.Vet Sci. 2019 Mar 2;6(1):22. doi: 10.3390/vetsci6010022. Vet Sci. 2019. PMID: 30832371 Free PMC article.
-
Tissue expression of MMP-9, TIMP-1, RECK, and miR338-3p in prostate gland: can it predict cancer?Mol Biol Res Commun. 2021 Dec;10(4):149-156. doi: 10.22099/mbrc.2021.40912.1646. Mol Biol Res Commun. 2021. PMID: 35097136 Free PMC article.
-
Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins.PLoS One. 2016 Jun 28;11(6):e0158116. doi: 10.1371/journal.pone.0158116. eCollection 2016. PLoS One. 2016. PMID: 27352049 Free PMC article.
-
Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.Med Sci Monit. 2015 Aug 19;21:2433-8. doi: 10.12659/MSM.894205. Med Sci Monit. 2015. PMID: 26286316 Free PMC article.
-
Efficacy of Buzhong Yiqi decoction on benign prostatic hyperplasia and its possible mechanism.J Tradit Chin Med. 2023 Jun;43(3):533-541. doi: 10.19852/j.cnki.jtcm.2023.03.003. J Tradit Chin Med. 2023. PMID: 37147755 Free PMC article.
References
-
- Castellano G, Malaponte G, Mazzarino MC, Figini M, Marchese F, Gangemi P, Travali S, Stivala F, Canevari S, Libra M. Activation of the osteopontine/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin Cancer Res. 2008;14:7470–80. - PubMed
-
- Vargas R, Jacobus S, Leitzel K, Regan MM, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali SM, Kantoff PW, Lipton A. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients. Cancer. 2011;117:517–25. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous